$1M Bet On Children's Place? Check Out These 3 Stocks Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insider trades were noted in three US-listed companies: Children's Place, Inc. (NASDAQ:PLCE), Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), and Nuvectis Pharma, Inc. (NASDAQ:NVCT). The CEO of Children's Place acquired 43,000 shares at an average price of $23.70, costing around $1.02 million. Black Diamond Therapeutics' Director bought 1,000,000 shares at an average price of $5.00, costing around $5 million. Nuvectis Pharma's 10% owner purchased 1,176 shares at an average price of $15.52, costing around $18,252.
July 07, 2023 | 11:19 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Black Diamond Therapeutics' Director bought 1,000,000 shares, indicating confidence in the company.
Insider trading, especially by high-ranking officials like the Director, often signals confidence in the company's prospects. This could potentially lead to a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Nuvectis Pharma's 10% owner bought 1,176 shares, indicating confidence in the company.
Insider trading, especially by significant shareholders, often signals confidence in the company's prospects. This could potentially lead to a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Children's Place CEO bought 43,000 shares, indicating confidence in the company.
Insider trading, especially by high-ranking officials like the CEO, often signals confidence in the company's prospects. This could potentially lead to a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100